Mareike Verbeek

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Silvia Spoerl, Nimitha R. Mathew, Michael Bscheider et al. · Blood · 2014 · 394 citations

Life Sciences, Immunology, Pharmacotherapy +14

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Michael Neuenhahn, Julia Albrecht, Marcus Odendahl et al. · Leukemia · 2017 · 161 citations · Full text

Medicine, Immunology, Infectious Diseases +12

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia

Peter Herhaus, Stefan Habringer, Kathrin Philipp‐Abbrederis et al. · Haematologica · 2016 · 66 citations · Full text

Medicine, Cancer Biology, Hematology +17